Given the recent uptick in COVID-19 cases in the US, many InCrowd panelists have been reporting that they do not expect things to return to normal until a vaccine is developed and disseminated. In order to deepen our understanding of the COVID-19 vaccine landscape, InCrowd surveyed infectious disease specialists across the country to get their perception and predictions on the efficacy, impact, and competitive landscape of COVID-19 vaccines.
Please note, views in this survey reflect opinions only, as reported by responding physicians.
- Method: 10-minute MicroSurvey via InCrowd
- Crowds: Infectious disease doctors
- Sample Size: n=100
- Fielding Period: June 26th – July 6th
InCrowd’s other COVID-19 Tracking Reports: